Eli Lilly and Company Breaks Ground on $5B Integrated Manufacturing Site in Virginia

Eli Lilly and Company has commenced construction on a $5 billion integrated manufacturing site near Richmond, Virginia, aimed at producing active pharmaceutical ingredients and finished antibody-drug conjugate medicines. This facility is expected to generate around 650 high-wage jobs and is part of the company's strategy to enhance its manufacturing capacity and vertically integrate its supply chain for advanced therapies.